ArticleMolecular biology reports2026
Serum vitamin D and VDR genetic variation in kidney stone disease: haplotype and gene-environment interaction analyses in a genetically homogeneous population.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSerum vitamin D status and vitamin D receptor (VDR) genetic variation may contribute to kidney stone disease (KSD) susceptibility, although their combined effects remain poorly understood. This study investigated the independent and combined effects of serum vitamin D status and VDR genetic variation on KSD susceptibility in a genetically homogeneous population.
methodsA case-control study was conducted on 267 KSD patients and 296 metabolically screened controls. Serum 25-hydroxyvitamin D was measured, and VDR ApaI, TaqI, and FokI polymorphisms were genotyped by PCR-RFLP. Haplotype, linkage disequilibrium, ROC, and additive gene-environment interaction analyses were performed.
resultsIndividual VDR polymorphisms were not significantly associated with KSD. However, elevated serum vitamin D was strongly associated with disease risk (OR = 12.55, 95% CI: 4.70-33.54; p < 0.001). ROC analysis identified an optimal vitamin D cut-off of 35.84 ng/mL (AUC = 0.816). Haplotype analysis identified GCC as a risk haplotype (OR = 4.08, 95% CI: 2.47-6.72), whereas GCT (OR = 0.21, 95% CI: 0.10-0.46) was protective. Additive interaction analyses demonstrated positive interactions between elevated serum vitamin D and the ApaI GT and FokI CC/CT genotypes, while TaqI variants showed antagonistic interactions.
conclusionThe study highlights that VDR haplotypes and serum vitamin D-VDR genotype interactions substantially modified disease risk, suggesting that integrating biochemical and genetic markers may improve KSD risk assessment and support precision prevention strategies.
Indexed as
Identifiers
42886391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.